Dystrophin isoform induction in vivo by antisense-mediated alternative splicing. - Wikidata - awgldk - TriplyDB

Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

http://www.wikidata.org/entity/Q33930110

about

Characterization of Dp71Δ(78-79), a novel dystrophin mutant that stimulates PC12 cell differentiation.The FSHD atrophic myotube phenotype is caused by DUX4 expression.Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals.Multiple exon skipping strategies to by-pass dystrophin mutations.Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD).Cell-matrix interactions in muscle disease.Translational development of splice-modifying antisense oligomers.Correcting the NLRP3 inflammasome deficiency in macrophages from autoimmune NZB mice with exon skipping antisense oligonucleotides.De novo sequencing of short interfering ribonucleic acids facilitated by use of tandem mass spectrometry with ion mobility spectrometry.Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics.

P2860

Q30273770-A033E9FE-E4E1-43AF-B261-B4074019FE88 Q34067055-5777CEC6-47DF-49E9-ACF4-58DF76D890CD Q34994545-63029894-5F96-440C-B14D-1C08CE228130 Q36186392-08C4866D-EACF-44FB-86B5-8DADC5078303 Q36369845-EA0EE919-45F5-4957-8768-02A413BD08DF Q37724109-562DF553-CCE1-4CEF-AFF4-1B2C7B424EBE Q37944530-6902C91D-A32E-4C0B-BE57-FC2D2F24A3B2 Q38996657-E269A225-10FB-4EF5-B6E1-D87B89A8FF13 Q40809647-015CB174-7E03-4A93-A56B-7DE898170308 Q45128033-40E38EDB-0322-4B26-8145-7E0EAA84DBE1 Q55638503-4D0ED430-FEEA-4008-9B2E-0A3A03ACC01D

P2860

Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

http://www.wikidata.org/entity/Q33930110

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

@ast

Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

@en

type

label

Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

@ast

Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

@en

prefLabel

Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

@ast

Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

@en

P1433

Q33930110-C0B7E04F-A317-4E9F-A515-9FC5A8938021

P1476

Q33930110-2E1B36AD-6DBF-44B7-B606-132B98358817

P2093

Q33930110-297BAD90-13AA-4DFA-9087-981DA3723A40

Q33930110-B33741DE-A932-4B68-AFEA-FDFE66924070

Q33930110-B9611035-239A-4126-9BB3-E6B6EAEC63F7

Q33930110-DAF9F9F0-E9A3-4C81-B872-E180543B24F4

Q33930110-EF66BFB9-4B8F-4DAC-BC8E-F5594A682BFD

P2860

Q33930110-01B90973-798E-47A7-B6F7-C661891BBD61

Q33930110-0A6A3C19-2B15-43F5-9C82-4627F8E85024

Q33930110-115923E2-61A5-4024-89FA-8AC637F3CB49

Q33930110-1F089658-6C6B-489A-8FF5-ABB5B34B8192

Q33930110-229E7415-0B1E-4DB8-9870-ED7CA376AD73

Q33930110-27E5F817-9025-45B8-90AB-056FEF548C93

Q33930110-34C716CA-9443-4D7E-AA3D-0F8EB143F6DA

Q33930110-350DE568-1586-4A65-8B8F-39B334E159CF

Q33930110-38554B3A-EE62-4CB8-9EC5-1C9F50DF5809

Q33930110-42382A5B-5CB5-405C-8988-D40F2FE403C5

P304

Q33930110-3CF7E840-03B5-4689-8298-61D9AD209D87

P31

Q33930110-06BA15D1-67AC-47D0-B0BC-666C9B4001EE

P356

Q33930110-E2C9F16D-9087-40C8-A5A2-4F12D86973FC

P433

Q33930110-41C64F56-C620-4A95-A202-8210894B3B5D

P478

Q33930110-2021312B-5644-4520-A472-F90D81D4D68D

P50

Q33930110-1C41AF6D-425C-4F77-A5FA-8DDDFCE034A3

P577

Q33930110-B1110A73-A53C-4C84-A638-0A41930B045F

P5875

Q33930110-1ADACE6E-9D94-457D-920D-3A9AE0D731FE

P698

Q33930110-40F1FE2E-72FB-4672-9BD1-D31E9FA08BBF

P932

Q33930110-A380EC27-5594-4A17-A355-55444FCDF4C0

P356

P1433

Molecular Therapy

P1476

Dystrophin isoform induction in vivo by antisense-mediated alternative splicing

@en

P2093

Abbie M Adams

http://www.w3.org/2001/XMLSchema#string

Hong M Moulton

http://www.w3.org/2001/XMLSchema#string

Kane Greer

http://www.w3.org/2001/XMLSchema#string

Russell D Johnsen

http://www.w3.org/2001/XMLSchema#string

Steve D Wilton

http://www.w3.org/2001/XMLSchema#string

P2860

Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries

The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein

Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin

Binding sites involved in the interaction of actin with the N-terminal region of dystrophin

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.

Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy

Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm.

Collaborating to bring new therapies to the patient--the TREAT-NMD model.

Morpholino oligos: making sense of antisense?

Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide.

P304

1218-1223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2010.45

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42441161

http://www.w3.org/2001/XMLSchema#string

P698

20332768

http://www.w3.org/2001/XMLSchema#string

P932

2889736

http://www.w3.org/2001/XMLSchema#string